SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 15th, 2009 • Cardium Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 15th, 2009 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 15, 2009, between Cardium Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
FIRST AMENDMENT TO LETTER AGREEMENTLetter Agreement • October 15th, 2009 • Cardium Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledOctober 15th, 2009 Company IndustryThis First Amendment (this “Amendment”) made effective as October 14, 2009 (the “Effective Date”) by and among Dawson James Securities, Inc., as lead placement agent (“DJS” or the “Placement Agent”) and Cardium Therapeutics, Inc. (the “Company”).